SEQENS
Jean-Pierre Pilleux currently serves as the Director of Operations at SEQENS, overseeing operations for the Innovative Business Unit, which includes four manufacturing facilities in France and the US. With extensive experience in project management and strategic initiatives, Pilleux has directed significant projects for the CDMO activities, including the industrialization of multiple APIs with a substantial development budget and modernization efforts at key manufacturing sites. Prior to SEQENS, Pilleux held several leadership roles at Novasep, including Site Director and Quality Assurance Director for Europe, where responsibilities encompassed the management of production, quality systems, and regulatory affairs across multiple sites. Pilleux's career also includes roles at Finorga, GlaxoSmithKline, and Zeneca, contributing expertise in quality assurance, validation, and analytical development. Educational credentials include a Master's degree in Quality Assurance and an Engineer's degree in Chemistry.
This person is not in any offices
SEQENS
SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients. The group generates a revenue of 1.4 MM€ and operates 24 manufacturing plants and 10 R&D centers in Europe, North America and Asia. 3,400 employees contribute to the success of SEQENS, among which 350 scientists, engineers and experts who develop tailor-made solutions for our customers. SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies.